Cervix Uteri Nos, Gestational Trophoblastic Disease, Uterine Cancer
Conditions
Keywords
GTD survivors, questionnaires, GTD
Brief summary
The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life. We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.
Interventions
BEHAVIORALquestionnaire
A patient questionnaire, which includes validated instruments. Data collection methods are as follows: * In person at the medical appointment * Over the telephone * Mailed with self-addressed return envelope and prepaid postage * E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
Sponsors
Memorial Sloan Kettering Cancer Center
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Pathology confirmed GTD by MSKCC * Sufficient proficiency in the English language to respond to quality of life surveys * Age ≥ 18 years * Benign or malignant disease * Treated with surgery and/or chemotherapy or observation
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes include reproductive concerns (as measured by the Reproductive Concern Scale, RCS) and sexual functioning (as measured by the Female Sexual Function Index, FSFI). | conclusion of the study |
Secondary
| Measure | Time frame |
|---|---|
| To describe the prevalence of premature menopause and increased bone loss through the Menopausal Symptom Check List and medical follow-up information. | conclusion of the study |
Countries
United States
Outcome results
None listed